Search

Author/Creator Thistlethwaite, F

1. 435PPreliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors. (23rd October 2018)

Authors:
Boni, V; Garcia-Corbacho, J; Ott, P A; Cho, D C; Autio, K A; Uboha, N; Spira, A I; Humphrey, R; Will, M; Naing, A; Thistlethwaite, F; de Vries, E G E; Arkenau, H-T
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 436PPreliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors. (23rd October 2018)

Authors:
Plummer, R; Sanborn, R E; de Vries, E G E; Lorusso, P; Arkenau, H-T; Uboha, N; Wydmanski, J; Fidler, M J; Boni, V; Garcia-Corbacho, J; Humphrey, R; Will, M; Autio, K A; El-Khoueiry, A B; Menke-van der Houven van Oordt, C W; Thistlethwaite, F
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P-11730-day mortality associated with systemic anti-cancer therapy (SACT) in gastrointestinal malignancies: The Christie experience. (20th June 2018)

Authors:
Marti, F Marti; McGurk, A; Alam, N; Bhatt, L; Braun, M; Hubner, R; Mansoor, W; McBain, C; McNamara, M; Mullamitha, S; Saunders, M; Sheikh, H; Thistlethwaite, F; Valle, J; Wilson, G; Hasan, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search